key: cord-1045562-wfo3ui5o authors: Phadke, Rachana; Mohan, Anmol; Çavdaroğlu, Sude; Dapke, Kartik; Costa, Ana Carla dos Santos; Riaz, Mehr Muhammad Adeel; Hashim, Hashim Talib; Essar, Mohammad Yasir; Ahmad, Shoaib title: Dengue amidst COVID‐19 in India: The mystery of plummeting cases date: 2021-04-06 journal: J Med Virol DOI: 10.1002/jmv.26987 sha: 98d813f5994a4b287f1d9bcd1ff869a265134daf doc_id: 1045562 cord_uid: wfo3ui5o India, seemingly, has curbed the cases of dengue which has been endemic in the country for many years. The decline in cases is surprising with some states reporting a massive decrease in dengue cases of 84% as compared to last year. This decline in cases can be attributable to a possible disparity in the data and a rather unmonitored outbreak or owing to the lockdowns, misdiagnosis, and social distancing amidst the COViD-19. The underlying factor should be explored and addressed as an unmonitored outbreak can lead to irrational pharmacotherapy, undiagnosed cases and a double burden on the healthcare system This article is protected by copyright. All rights reserved. To the Editor, India has been fighting COVID-19 for more than a year now, facing numerous difficulties and losses. The country's health system, despite adversities owing to the lack of resources and trained professionals in the poorest regions, 1 has proven to be efficient enough to bring down, over time, the growing trends of this disease. 2 Channelling the available health resources to fight COVID-19 seemed plausible and proved effective indeed. However, with the saturation of health resources and the justified intense heed towards COVID-19, India is in danger of worsening the epidemiological profile of dengue in the country. In recent years, dengue, an arbovirus transmitted by arthropods, has shown an increasing trend in the number of cases in the country, therefore requiring urgent public policies to curb the disease. However, in 2020, as the maximum capacity of health resources, such as hospitals, laboratory tests, labour, and epidemiological surveillance, was allocated to treat COVID-19 cases, there was a major setback in terms of coping, diagnosis, and treatment of other diseases, including dengue. Regarding dengue in India, the situation becomes evident on comparing the epidemiological reports from the past 5 years. 2020 saw an evident decrease in dengue cases, with Maharashtra showing a marked decline of 84%, when compared to 2019. 3 Two possible factors could have contributed to this reduction in number of cases. One being the lower transmission of the vector due to lockdown and social distancing, and the other being a significant disparity in the reported data of dengue cases. This disparity can be attributable to an increased attention to the current pandemic, under-diagnosis due to somewhat similar clinical picture to COVID-19 and the lack of available tests owing to a struggling health care system amidst the pandemic. Several factors corroborate for the second hypothesis to be the more plausible, with the diagnostic complexity between the two being very challenging for the health care professionals as both diseases exhibit nonspecific symptoms like fever, headache, body pain, abdominal pain, malaise, etc., and, therefore, making a differential diagnosis is an arduous feat in itself. Additionally, using complementary tests at that point can prove to be an ineffective strategy. Several studies have shown that both the viruses share similar biochemical and haematological findings, such as leukopenia and thrombocytopenia. In addition, a false-positive IgM for dengue has also been identified in serological tests in patients with confirmed COVID-19. [4] [5] [6] Despite a similar clinical presentation, these diseases differ regarding treatment and potential complications. The irrational pharmacotherapy as a result of a misdiagnosis can be fatal for a patient. For example, in moderate to severe COVID-19 cases, LMWH can be used for resolution/ prevention of thrombosis. In contrary to that LMWH in a dengue patient will cause an increased risk of bleeding. 7 The situation is quite alarming, because erroneous diagnoses, in addition to causing a delay in the initiation of adequate treatment and irrational pharmacotherapy, can also lead to increased mortality rates, greater complications, and hence an increased burden on the health To reduce the burden of dengue epidemic in the country, it is necessary to implement measures that allow the early detection of dengue cases, especially severe cases, to allow an adequate early management. Therefore, health teams, both in primary care and in reference services, need to be trained in the early and more reliable diagnosis of cases. 11 Situation of India in the COVID-19 Pandemic: India's Initial Pandemic Experience Our World in Data Sharp fall in dengue cases: Times of India A Patient With Dengue Fever and COVID-19: Coinfection or Not? Burden of Dengue Infection in India, 2017: A Cross-Sectional Population Based Serosurvey Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever Covert COVID-19 and false-positive dengue serology in Singapore Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever Chikungunya and COVID-19 in Brazil: the danger of overlapping crises PubMed Central (PMC) A double burden to Brazil Global strategy for dengue prevention and control Mehr Muhammad Adeel Riaz http://orcid.org/0000-0002- Hashim Talib Hashim http://orcid.org/0000-0001-6155-7302Mohammad Yasir Essar http://orcid.org/0000-0002-6554-7619Shoaib Ahmad http://orcid.org/0000-0002-7241-7724